Literature DB >> 21228088

Challenging symptom profiles of life-limiting conditions in children: a survey of care professionals and families.

Cari Malcolm1, Liz Forbat, Gillian Anderson, Faith Gibson, Richard Hain.   

Abstract

This paper reports on data from the initial phase of a UK-wide study exploring life-limiting conditions (LLCs) in children where, because of their rarity, little is understood regarding the significant symptom challenges of families and care professionals who support them. In this initial phase, care professionals (n=43) and families (n=16) completed a survey to identify which rare LLCs present symptom challenges and which individual symptoms prove difficult to manage. Findings led to the prioritization of mucopolysaccharidoses, Batten Disease and leukodystrophy. Care professionals' rationales for selecting these conditions included the presence of symptoms that are very difficult to manage, a requirement for additional clinical evidence to support symptom management, and the progressive nature of these diseases where symptoms frequently change and are difficult to predict. Families identified symptoms such as behavioural difficulties, visual impairments and communication impairments as those being most difficult to manage and having most impact on quality of life for children and families.
© The Author(s) 2011

Entities:  

Mesh:

Year:  2011        PMID: 21228088     DOI: 10.1177/0269216310391346

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  15 in total

1.  Clinical trials in rare disease: challenges and opportunities.

Authors:  Erika F Augustine; Heather R Adams; Jonathan W Mink
Journal:  J Child Neurol       Date:  2013-09       Impact factor: 1.987

2.  Charting the Territory: Children and families living with progressive life-threatening conditions.

Authors:  Harold Siden; Rose Steele
Journal:  Paediatr Child Health       Date:  2015-04       Impact factor: 2.253

3.  Parental social support, coping strategies, resilience factors, stress, anxiety and depression levels in parents of children with MPS III (Sanfilippo syndrome) or children with intellectual disabilities (ID).

Authors:  Sheena Grant; Elaine Cross; James Edmond Wraith; Simon Jones; Louise Mahon; Michelle Lomax; Brian Bigger; Dougal Hare
Journal:  J Inherit Metab Dis       Date:  2012-11-15       Impact factor: 4.982

4.  An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-III.

Authors:  Elaine M Cross; Sheena Grant; Simon Jones; Brian W Bigger; James E Wraith; Louise V Mahon; Michelle Lomax; Dougal J Hare
Journal:  J Neurodev Disord       Date:  2014-12-31       Impact factor: 4.025

5.  Parents' experiences of living with, and caring for children, adolescents and young adults with Mucopolysaccharidosis (MPS).

Authors:  S Somanadhan; P J Larkin
Journal:  Orphanet J Rare Dis       Date:  2016-10-10       Impact factor: 4.123

6.  Use of buccal morphine in the management of pain in children with life-limiting conditions: Results of a laboratory study.

Authors:  Renée McCulloch; Mohammed Sattar; Ellen M Henderson; Majella E Lane; Myra Bluebond-Langner
Journal:  Palliat Med       Date:  2017-06-20       Impact factor: 4.762

7.  Pain reporting and analgesia management in 270 children with a progressive neurologic, metabolic or chromosomally based condition with impairment of the central nervous system: cross-sectional, baseline results from an observational, longitudinal study.

Authors:  Stefan J Friedrichsdorf; Andrea C Postier; Gail S Andrews; Karen Es Hamre; Rose Steele; Harold Siden
Journal:  J Pain Res       Date:  2017-07-31       Impact factor: 3.133

Review 8.  Emerging Methodologies in Pediatric Palliative Care Research: Six Case Studies.

Authors:  Katherine E Nelson; James A Feinstein; Cynthia A Gerhardt; Abby R Rosenberg; Kimberley Widger; Jennifer A Faerber; Chris Feudtner
Journal:  Children (Basel)       Date:  2018-02-26

9.  Challenges of palliative care in children with inborn metabolic diseases.

Authors:  Jessica I Hoell; Jens Warfsmann; Felix Distelmaier; Arndt Borkhardt; Gisela Janßen; Michaela Kuhlen
Journal:  Orphanet J Rare Dis       Date:  2018-07-09       Impact factor: 4.123

10.  A mixed-methods systematic review and meta-analysis of barriers and facilitators to paediatric symptom management at end of life.

Authors:  Katie Greenfield; Simone Holley; Daniel E Schoth; Emily Harrop; Richard F Howard; Julie Bayliss; Lynda Brook; Satbir S Jassal; Margaret Johnson; Ian Wong; Christina Liossi
Journal:  Palliat Med       Date:  2020-03-31       Impact factor: 4.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.